Drug-resistant gonorrhea on the rise in Europe, ECDC warns
11 Articles
11 Articles
Drug-resistant gonorrhea on the rise in Europe, ECDC warns
Alongside growing evidence of the domestic spread of such resistant strains in Europe over the past two years, this poses a significant challenge for future treatment options for one of the most common sexually transmitted diseases worldwide, according to an assessment issued by the European Center for Disease Prevention and Control (ECDC).
According to estimates, approximately 82 million infections occur worldwide each year. In 2024, over 106,000 cases were confirmed in European Union and European Economic Area countries – the highest number since the beginning of EU epidemiological surveillance in 2009. Currently, European guidelines recommend treating gonorrhea with ceftriaxone. This antibiotic became the mainstay of therapy after the disease-causing bacterium Neisseria gonorrho…
Newswise
Business News This WeekDrug-resistant gonorrhea: Why it matters and what comes next
Drug-resistant Neisseria gonorrhoeae (the bacterium that causes gonorrhea) has become one of the most urgent antimicrobial resistant threats to public health worldwide. As gonorrhea rates rise and treatment options become more limited, researchers are calling for a more tailored approach that combines new diagnostics, rapid resistance testing, surveillance and additional treatment options for the sexually transmitted disease.
Europe is facing a serious health threat. More and more cases of antibiotic-resistant gonorrhea are appearing in European countries, and experts warn that infections are increasingly being transmitted locally, not just imported from abroad. As reported by euronews, the effectiveness of available treatments is declining, and the number of infections is reaching historic highs.
Coverage Details
Bias Distribution
- 50% of the sources are Center, 50% of the sources lean Right
Factuality
To view factuality data please Upgrade to Premium
